IPHA
Price
$2.14
Change
+$0.02 (+0.94%)
Updated
May 21 closing price
Capitalization
199.79M
MDGL
Price
$278.09
Change
+$0.85 (+0.31%)
Updated
May 22, 11:02 AM (EDT)
Capitalization
6.5B
76 days until earnings call
Interact to see
Advertisement

IPHA vs MDGL

Header iconIPHA vs MDGL Comparison
Open Charts IPHA vs MDGLBanner chart's image
Innate Pharma SA
Price$2.14
Change+$0.02 (+0.94%)
Volume$13.67K
Capitalization199.79M
Madrigal Pharmaceuticals
Price$278.09
Change+$0.85 (+0.31%)
Volume$100
Capitalization6.5B
IPHA vs MDGL Comparison Chart
Loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHA vs. MDGL commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a StrongBuy and MDGL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (IPHA: $2.14 vs. MDGL: $277.24)
Brand notoriety: IPHA and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 30% vs. MDGL: 158%
Market capitalization -- IPHA: $199.79M vs. MDGL: $6.5B
IPHA [@Biotechnology] is valued at $199.79M. MDGL’s [@Biotechnology] market capitalization is $6.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 1 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • IPHA’s FA Score: 1 green, 4 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, MDGL is a better buy in the long-term than IPHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 6 TA indicator(s) are bullish while MDGL’s TA Score has 2 bullish TA indicator(s).

  • IPHA’s TA Score: 6 bullish, 5 bearish.
  • MDGL’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, IPHA is a better buy in the short-term than MDGL.

Price Growth

IPHA (@Biotechnology) experienced а +2.88% price change this week, while MDGL (@Biotechnology) price change was -1.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.18%. For the same industry, the average monthly price growth was +6.79%, and the average quarterly price growth was -1.65%.

Reported Earning Dates

IPHA is expected to report earnings on May 13, 2025.

MDGL is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($6.5B) has a higher market cap than IPHA($200M). IPHA YTD gains are higher at: 16.304 vs. MDGL (-10.153).
IPHAMDGLIPHA / MDGL
Capitalization200M6.5B3%
EBITDAN/A-376.15M-
Gain YTD16.304-10.153-161%
P/E RatioN/AN/A-
RevenueN/A317M-
Total CashN/A843M-
Total DebtN/A120M-
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
41
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPHAMDGL
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
70%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 15 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ITCTX28.49N/A
N/A
VY® T. Rowe Price Capital Apprec S2
TVRAX16.57N/A
N/A
NAA Allocation Fund A
AUIZX32.69N/A
N/A
AB Equity Income Z
FSTLX32.62N/A
N/A
Federated Hermes MDT Large Cap Value R6
FSUMX14.10N/A
N/A
Fidelity Series Sustainable U.S. Market

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
+0.94%
MDGL - IPHA
43%
Loosely correlated
-5.30%
SLNO - IPHA
34%
Loosely correlated
-2.33%
VALN - IPHA
30%
Poorly correlated
-1.70%
QSI - IPHA
28%
Poorly correlated
-12.20%
VKTX - IPHA
27%
Poorly correlated
-4.95%
More